KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases
Dr Marina Garassino - National Tumor Institute, Milan, Italy
KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases ( Dr Marina Garassino - National Tumor Institute, Milan, Italy )
15 Apr 2019
Immune checkpoint inhibitor combination efficacious for patients with high-grade...
Prof Sandip Patel - UC San Diego, San Diego, USA
Immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine carcinoma ( Prof Sandip Patel - UC San Diego, San Diego, USA )
11 Apr 2019
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brou...
Prof Josep Llovet, Dr Richard Finn
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )
25 Feb 2019
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic pr...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah )
25 Oct 2018
Two important pancreatic studies: PRODIGE 24 and PREOPANC
Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA
Two important pancreatic studies: PRODIGE 24 and PREOPANC ( Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Aug 2018
MyPathway study: a novel precision oncology multiple basket trial
Dr Mary S. Beattie - Genentech, USA
MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )
6 Jul 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Jul 2018
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )
24 Jun 2018
Pancreatic survival improved with trial chemotherapy regimen after surgery
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Pancreatic survival improved with trial chemotherapy regimen after surgery ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
4 Jun 2018
Comment: Pancreatic cancer survival extended by over a year with chemotherapy re...
Dr Andrew Epstein and Prof Richard Schilsky
Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Andrew Epstein and Prof Richard Schilsky )
4 Jun 2018
Pancreatic cancer survival extended by over a year with chemotherapy regimen
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
4 Jun 2018
New pathways in pancreatic cancer
Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA
New pathways in pancreatic cancer ( Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA )
3 Jun 2018